Table 1 Base-case probabilistic cost-effectiveness scenario for bioimpedance guided fluid management versus standard practice (excluding dialysis costs)
| Strategy | Mean costs | Incremental costs | Mean QALYs | Incremental QALYs | ICER | Probability cost-effective at £20,000 threshold |
|---|---|---|---|---|---|---|
| Clinical effectiveness: applying linked effects on mortality and non-fatal CV events through the pooled reduction in pulse wave velocity (HR = 0.9318 on both CV events and mortality) | ||||||
| Standard care | £46,097 | 2.7031 | 0.407 | |||
| BCM | £47,994 | £1896 | 2.8177 | 0.1147 | £16,536 | 0.593 |